Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karin Haustermans

Showing results (181-190 of 285) with videos related to

Pageof 29
Sort By:
The Journal of Urology|November 14, 2019
Development and External Validation of a Multiparametric Magnetic Resonance Imaging and International Society of Urological Pathology Based Add-On Prediction Tool to Identify Prostate Cancer Candidates for Pelvic Lymph Node DissectionCédric Draulans, Wouter Everaerts, Sofie Isebaert, et al.
BMC Cancer|April 3, 2018
Neoadjuvant degarelix with or without apalutamide followed by radical prostatectomy for intermediate and high-risk prostate cancer: ARNEO, a randomized, double blind, placebo-controlled trialLorenzo Tosco, Annouschka Laenen, Thomas Gevaert, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 27, 2010
First report on the patient database for the identification of the genetic pathways involved in patients over-reacting to radiotherapy: GENEPI-IIDirk De Ruysscher, Diane Severin, Elizabeth Barnes, et al.
Advances in Radiation Oncology|December 29, 2022
Ultrahigh-Dose-Rate Proton Irradiation Elicits Reduced Toxicity in Zebrafish EmbryosGaëlle Saade, Eva Bogaerts, Sophie Chiavassa, et al.
Trials|December 7, 2011
Single blind randomized phase III trial to investigate the benefit of a focal lesion ablative microboost in prostate cancer (FLAME-trial): study protocol for a randomized controlled trialIrene M Lips, Uulke A van der Heide, Karin Haustermans, et al.
European Urology|December 19, 2013
Prediction of outcome following early salvage radiotherapy among patients with biochemical recurrence after radical prostatectomyAlberto Briganti, R Jeffrey Karnes, Steven Joniau, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 15, 2010
Adjuvant gemcitabine alone versus gemcitabine-based chemoradiotherapy after curative resection for pancreatic cancer: a randomized EORTC-40013-22012/FFCD-9203/GERCOR phase II studyJean-Luc Van Laethem, Pascal Hammel, Françoise Mornex, et al.
Critical Reviews in Oncology/Hematology|May 8, 2017
Systematic review and meta-analysis of local resection or transanal endoscopic microsurgery versus radical resection in stage i rectal cancer: A real standard?Geneviève Veereman, Joan Vlayen, Jo Robays, et al.
The Lancet. Gastroenterology & Hepatology|May 19, 2026
Management of colorectal cancer in older adults: an expert panel recommendation to guide daily clinical practiceGabor Liposits, Thierry André, Thomas Aparicio, et al.
Journal of Geriatric Oncology|June 30, 2026
Management of older adults with colorectal cancer - The state-of-the-art in 2026Gabor Liposits, Thierry André, Thomas Aparicio, et al.
Pageof 29

Showing results (181-190 of 285) with videos related to

Sort By:
Pageof 29
The Journal of Urology|November 14, 2019
Development and External Validation of a Multiparametric Magnetic Resonance Imaging and International Society of Urological Pathology Based Add-On Prediction Tool to Identify Prostate Cancer Candidates for Pelvic Lymph Node DissectionCédric Draulans, Wouter Everaerts, Sofie Isebaert, et al.
BMC Cancer|April 3, 2018
Neoadjuvant degarelix with or without apalutamide followed by radical prostatectomy for intermediate and high-risk prostate cancer: ARNEO, a randomized, double blind, placebo-controlled trialLorenzo Tosco, Annouschka Laenen, Thomas Gevaert, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 27, 2010
First report on the patient database for the identification of the genetic pathways involved in patients over-reacting to radiotherapy: GENEPI-IIDirk De Ruysscher, Diane Severin, Elizabeth Barnes, et al.
Advances in Radiation Oncology|December 29, 2022
Ultrahigh-Dose-Rate Proton Irradiation Elicits Reduced Toxicity in Zebrafish EmbryosGaëlle Saade, Eva Bogaerts, Sophie Chiavassa, et al.
Trials|December 7, 2011
Single blind randomized phase III trial to investigate the benefit of a focal lesion ablative microboost in prostate cancer (FLAME-trial): study protocol for a randomized controlled trialIrene M Lips, Uulke A van der Heide, Karin Haustermans, et al.
European Urology|December 19, 2013
Prediction of outcome following early salvage radiotherapy among patients with biochemical recurrence after radical prostatectomyAlberto Briganti, R Jeffrey Karnes, Steven Joniau, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 15, 2010
Adjuvant gemcitabine alone versus gemcitabine-based chemoradiotherapy after curative resection for pancreatic cancer: a randomized EORTC-40013-22012/FFCD-9203/GERCOR phase II studyJean-Luc Van Laethem, Pascal Hammel, Françoise Mornex, et al.
Critical Reviews in Oncology/Hematology|May 8, 2017
Systematic review and meta-analysis of local resection or transanal endoscopic microsurgery versus radical resection in stage i rectal cancer: A real standard?Geneviève Veereman, Joan Vlayen, Jo Robays, et al.
The Lancet. Gastroenterology & Hepatology|May 19, 2026
Management of colorectal cancer in older adults: an expert panel recommendation to guide daily clinical practiceGabor Liposits, Thierry André, Thomas Aparicio, et al.
Journal of Geriatric Oncology|June 30, 2026
Management of older adults with colorectal cancer - The state-of-the-art in 2026Gabor Liposits, Thierry André, Thomas Aparicio, et al.
Pageof 29